MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Martin Lange
Martin LangeNOVO NORDISK

Martin Lange

Chief Scientific Officer and Executive Vice President at NOVO NORDISK

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 3.51 B
Avg. Deal Size£ 3.51 B

Market Context

Sort

09 Oct 2025|United States|Biotechnology
Akero Therapeutics
Novo Nordisk

Target: AKERO THERAPEUTICS

Bidder: NOVO NORDISK

5 Service Providers

1 Target | 4 Bidder

10 Dealmakers

10 Bidder

£ 3.51 B

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Martin Lange